SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q4 2025
Institutional positions in SAB Biotherapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +14 vs. Q3 2025
- Shares held
- 36.3M
- +8.32M (+29.7%) vs. Q3 2025
- Total value
- $135.9M
- +$79.6M (+141.3%) vs. Q3 2025
- New holders
- 21
- 11 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 50 | $187 | 0.00% | −2−3.8% | Reduced |
| Harbour Investments, Inc. | 50 | $187 | 0.00% | 00.0% | Unchanged |
| Gs Investments, Inc. | 200 | $748 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 217 | $812 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,990 | $7.44K | 0.00% | +1,903+2,187.4% | Added |
| Morgan Stanley | 4,262 | $15.9K | 0.00% | +4,094+2,436.9% | Added |
| Advisor Group Holdings, Inc. | 5,024 | $18.8K | 0.00% | +200+4.1% | Added |
| UBS Group AG | 7,398 | $27.7K | 0.00% | −5,823−44.0% | Reduced |
| State of Wyoming | 8,971 | $33.6K | 0.00% | +8,971 | New |
| Caxton Corp | 10,527 | $39.4K | 0.92% | −408−3.7% | Reduced |
| Bank of America Corp | 10,613 | $39.7K | 0.00% | +10,539+14,241.9% | Added |
| Kestra Advisory Services, LLC | 11,550 | $43.2K | 0.00% | −380−3.2% | Reduced |
| State Street Corp | 13,122 | $49.1K | 0.00% | +13,122 | New |
| Fifth Lane Capital, LP | 15,000 | $56.1K | 0.07% | +15,000 | New |
| Northern Trust Corp | 16,412 | $61.4K | 0.00% | +5,025+44.1% | Added |
| BlackRock, Inc. | 17,239 | $64.5K | 0.00% | +10,900+172.0% | Added |
| Citadel Advisors LLC | 17,650 | $66.0K | 0.00% | +17,650 | New |
| First PREMIER Bank | 18,986 | $71.0K | 0.02% | 00.0% | Unchanged |
| Colony Group, LLC | 19,201 | $71.8K | 0.00% | +19,201 | New |
| Persistent Asset Partners Ltd | 19,790 | $74.0K | 0.04% | +19,790 | New |
| ADAR1 Capital Management, LLC | 26,344 | $98.5K | 0.01% | +11,344+75.6% | Added |
| Verition Fund Management LLC | 26,867 | $100.5K | 0.00% | +26,867 | New |
| Citigroup Inc | 29,974 | $112.1K | 0.00% | +29,142+3,502.6% | Added |
| Qube Research & Technologies Ltd | 31,147 | $116.5K | 0.00% | +31,147 | New |
| Omers Administration Corp | 42,000 | $157.1K | 0.00% | +42,000 | New |
| Pathstone Holdings, LLC | 50,650 | $189.4K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 51,348 | $192.0K | 0.00% | +40,127+357.6% | Added |
| ExodusPoint Capital Management, LP | 86,113 | $322.1K | 0.00% | +86,113 | New |
| Geode Capital Management, LLC | 119,517 | $447.0K | 0.00% | +33,799+39.4% | Added |
| StemPoint Capital LP | 146,558 | $548.1K | 0.09% | +146,558 | New |
| AWM Investment Company, Inc. | 200,000 | $748.0K | 0.07% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 208,227 | $778.8K | 0.01% | +208,227 | New |
| Marshall Wace, LLP | 236,460 | $884.4K | 0.00% | +236,460 | New |
| Ameriprise Financial Inc | 283,645 | $1.06M | 0.00% | +283,645 | New |
| HB Wealth Management, LLC | 307,500 | $1.15M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 324,090 | $1.21M | 0.00% | +324,090 | New |
| Balyasny Asset Management LLC | 475,439 | $1.78M | 0.00% | +475,439 | New |
| Jefferies Financial Group Inc. | 580,328 | $2.17M | 0.02% | +580,328 | New |
| Propel Bio Management, LLC | 652,881 | $2.44M | 2.08% | +652,881 | New |
| Perceptive Advisors LLC | 803,210 | $3.00M | 0.06% | +803,210 | New |
| Vanguard Group Inc | 1,847,136 | $6.91M | 0.00% | +1,481,383+405.0% | Added |
| Blackstone Group Inc. | 2,143,585 | $8.02M | 0.03% | +2,143,585 | New |
| Sessa Capital IM, L.P. | 2,198,457 | $8.22M | 0.16% | 00.0% | Unchanged |
| Spruce Street Capital LP | 2,198,502 | $8.22M | 2.72% | +2,198,502 | New |
| Woodline Partners LP | 2,850,881 | $10.7M | 0.04% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,401,500 | $16.5M | 0.17% | 00.0% | Unchanged |
| Commodore Capital LP | 4,401,500 | $16.5M | 1.10% | 00.0% | Unchanged |
| Vivo Capital, LLC | 11,420,000 | $42.7M | 2.76% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −932,697−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −566,395−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −80,840−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,982−100.0% | Sold out |
| Kovitz Investment Group Partners, LLC | 0 | $0 | 0.00% | −19,201−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −15,781−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,560−100.0% | Sold out |